| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | FLOT2 |
| Uniprot No | Q14254 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 50-428aa |
| 氨基酸序列 | MTLQPRCEDVETAEGVALTVTGVAQVKIMTEKELLAVACEQFLGKNVQDI KNVVLQTLEGHLRSILGTLTVEQIYQDRDQFAKLVREVAAPDVGRMGIEI LSFTIKDVYDKVDYLSSLGKTQTAVVQRDADIGVAEAERDAGIREAECKK EMLDVKFMADTKIADSKRAFELQKSAFSEEVNIKTAEAQLAYELQGAREQ QKIRQEEIEIEVVQRKKQIAVEAQEILRTDKELIATVRRPAEAEAHRIQQ IAEGEKVKQVLLAQAEAEKIRKIGEAEAAVIEAMGKAEAERMKLKAEAYQ KYGDAAKMALVLEALPQIAAKIAAPLTKVDEIVVLSGDNSKVTSEVNRLL AELPASVHALTGVDLSKIPLIKKATGVQV |
| 预测分子量 | 67 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于FLOT2重组蛋白的3篇参考文献示例(部分信息基于假设性研究整合，供参考)：
---
1. **文献名称**：*"Expression and Functional Characterization of Recombinant Human FLOT2 Protein in Cancer Cell Signaling"*
**作者**：Li, X., Chen, Y., & Wang, J.
**摘要**：本研究成功在大肠杆菌系统中表达并纯化重组FLOT2蛋白，通过体外实验证实其通过调控EGFR/AKT信号通路促进肺癌细胞的迁移和侵袭，为FLOT2在肿瘤转移中的作用机制提供了分子证据。
2. **文献名称**：*"Structural Insights into FLOT2 Recombinant Protein and Its Role in Membrane Microdomain Organization"*
**作者**：Kumar, S., Müller, P., & Schneider, D.
**摘要**：利用重组FLOT2蛋白的晶体结构解析，揭示了其N端螺旋结构域在脂筏(lipid rafts)组装中的关键作用，并证明其通过胆固醇依赖性的方式参与细胞膜动态调节。
3. **文献名称**：*"Development of a FLOT2-Based Recombinant Protein Vaccine Targeting Metastatic Melanoma"*
**作者**：Garcia, R., et al.
**摘要**：研究将重组FLOT2蛋白作为肿瘤相关抗原，在小鼠模型中诱导特异性T细胞免疫应答，显著抑制黑色素瘤转移，提示其作为新型癌症疫苗的潜在应用价值。
---
**注**：以上文献为示例性质，实际引用时建议通过PubMed或Google Scholar以关键词“FLOT2 recombinant protein”“flotillin-2 expression”检索最新研究。若需具体文献，可提供更详细的研究方向以进一步筛选。
**Background of FLOT2 Recombinant Protein**
FLOT2 (Flotillin-2), a member of the flotillin family, is a conserved, membrane-associated protein implicated in diverse cellular processes, including endocytosis, membrane trafficking, and signal transduction. It is ubiquitously expressed in eukaryotic cells and localizes to lipid rafts, specialized membrane microdomains enriched in cholesterol and sphingolipids. FLOT2 forms hetero-oligomeric complexes with its homolog FLOT1. functioning as scaffolding proteins to organize membrane-associated signaling platforms. Structurally, FLOT2 contains a prohibitin homology (PHB) domain and a C-terminal coiled-coil region, which mediate protein-protein interactions and membrane association.
FLOT2 is crucial for cellular processes such as actin cytoskeleton remodeling, receptor tyrosine kinase signaling, and vesicle trafficking. It interacts with key regulators like EGFR, caveolin-1. and integrins, modulating pathways like PI3K/AKT and MAPK, which are central to cell proliferation, survival, and migration. Dysregulation of FLOT2 has been linked to cancer progression, where its overexpression correlates with enhanced tumor invasion, metastasis, and poor prognosis. Studies highlight its role in promoting epithelial-mesenchymal transition (EMT) and matrix metalloproteinase (MMP) secretion, facilitating extracellular matrix remodeling.
Recombinant FLOT2 proteins, produced via heterologous expression systems (e.g., *E. coli*, mammalian cells), are essential tools for *in vitro* studies. These purified proteins retain functional domains, enabling researchers to investigate FLOT2’s biochemical interactions, structural properties, and therapeutic potential. Applications include drug screening, antibody development, and mechanistic studies of FLOT2-associated pathologies, particularly cancer and neurodegenerative diseases. By elucidating FLOT2’s role in disease mechanisms, recombinant variants contribute to targeted therapy development and biomarker discovery.
×
